Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....
Zogenix to Present at the Jefferies 2017 Global Healthcare Conference
May 31, 2017 12:10 pm UTC| Business
EMERYVILLE, Calif., May 31, 2017 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P....